UPDATED May 13, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
IMMO | €29.45 | 0% | -29.9% | €293.7m | €46.00 | PS1.9x | E110.8% | 4.1% | Real Estate Management and Development | ||
ABO | €5.60 | 1.8% | -4.3% | €59.2m | €6.80 | PE23.4x | E29.0% | n/a | Commercial Services | ||
ARGX | €342.20 | -5.8% | -8.8% | €20.3b | €432.87 | PS15.1x | E60.1% | n/a | Pharmaceuticals & Biotech | ||
UCB | €122.05 | 2.3% | 41.3% | €23.2b | €125.49 | PE67.5x | E26.3% | 1.1% | Pharmaceuticals & Biotech | ||
SOLB | €34.31 | 12.8% | -67.3% | €3.6b | €37.94 | PB2.9x | E36.0% | 7.1% | Materials |